Literature DB >> 8016072

Radiation inactivation of human gamma-interferon: cellular activation requires two dimers.

J A Langer1, A Rashidbaigi, G Garotta, E Kempner.   

Abstract

gamma-Interferon (IFN-gamma) is a 17-kDa broad-spectrum cytokine which exerts its effects on a variety of target cells through its interaction with the IFN-gamma receptor. Although physicochemical studies of Escherichia coli-derived IFN-gamma, as well as its crystal structure, demonstrate that it is a homodimer in solution (M(r) 34,000), previous radiation inactivation studies yielded a functional size for IFN-gamma of 63-73 kDa in an antiviral assay. To understand the relationship between the solution form of IFN-gamma and the moiety that actually binds to the cellular receptor and activates cells, we examined irradiated nonradioactive and 32P-labeled IFN-gamma for its migration in SDS/polyacrylamide gels (to determine its physical integrity), its binding to cells, its reactivity in an ELISA, and its antiviral activity. The functional size of IFN-gamma differed in the assays, being 22 +/- 2 kDa for the physical destruction of IFN-gamma, 56 +/- 2 kDa for the cellular binding assay, 45-50 kDa for reactivity in the ELISA, and 72 +/- 6 kDa for antiviral activity. The results from the binding assays constitute direct evidence that IFN-gamma binds to its cellular receptor as a dimer. However, for antiviral activity, the functional mass is equivalent to a tetramer. This is consistent with models involving ligand-induced receptor dimerization, whereby two dimers acting in concert (equivalent to the target size of a tetramer) are required to activate cells in the antiviral assay.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8016072      PMCID: PMC44088          DOI: 10.1073/pnas.91.13.5818

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

1.  Immune (gamma) interferon produced by a human T-lymphoblast cell line.

Authors:  I Nathan; J E Groopman; S G Quan; N Bersch; D W Golde
Journal:  Nature       Date:  1981-08-27       Impact factor: 49.962

2.  A convenient and rapid cytopathic effect inhibition assay for interferon.

Authors:  P C Familletti; S Rubinstein; S Pestka
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

3.  Expression of human immune interferon cDNA in E. coli and monkey cells.

Authors:  P W Gray; D W Leung; D Pennica; E Yelverton; R Najarian; C C Simonsen; R Derynck; P J Sherwood; D M Wallace; S L Berger; A D Levinson; D V Goeddel
Journal:  Nature       Date:  1982-02-11       Impact factor: 49.962

4.  Molecular weight of the functional unit of human leukocyte, fibroblast, and immune interferons.

Authors:  S Pestka; B Kelder; P C Familletti; J A Moschera; R Crowl; E S Kempner
Journal:  J Biol Chem       Date:  1983-08-25       Impact factor: 5.157

5.  Radiation inactivation of oligomeric enzyme systems: theoretical considerations.

Authors:  A S Verkman; K Skorecki; D A Ausiello
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

6.  Effect of glycosidases on the properties of human interferon gamma.

Authors:  M Tsujimoto; T Tarutani; K Ogawa; N Higashi
Journal:  J Interferon Res       Date:  1984

7.  Partial purification and characterization of human gamma (immune) interferon.

Authors:  Y K Yip; R H Pang; C Urban; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

8.  Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells.

Authors:  R Devos; H Cheroutre; Y Taya; W Degrave; H Van Heuverswyn; W Fiers
Journal:  Nucleic Acids Res       Date:  1982-04-24       Impact factor: 16.971

9.  A novel member of the interferon receptor family complements functionality of the murine interferon gamma receptor in human cells.

Authors:  S Hemmi; R Böhni; G Stark; F Di Marco; M Aguet
Journal:  Cell       Date:  1994-03-11       Impact factor: 41.582

10.  Large-scale production and physicochemical characterization of human immune interferon.

Authors:  M P Langford; J A Georgiades; G J Stanton; F Dianzani; H M Johnson
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

View more
  4 in total

1.  Identification and functional characterization of a second chain of the interleukin-10 receptor complex.

Authors:  S V Kotenko; C D Krause; L S Izotova; B P Pollack; W Wu; S Pestka
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

Review 2.  IFN-γ: A cytokine at the right time, is in the right place.

Authors:  J Daniel Burke; Howard A Young
Journal:  Semin Immunol       Date:  2019-06-17       Impact factor: 11.130

3.  Hypoxia-induced down-regulation of CYP1A1/1A2 and up-regulation of CYP3A6 involves serum mediators.

Authors:  Caroline Fradette; Anne-Marie Bleau; Vincent Pichette; Nathalie Chauret; Patrick Du Souich
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

4.  Intrauterine inhibition of chemokine receptor 4 signaling modulates local and systemic inflammation in ovine pregnancy.

Authors:  Stacia Z McIntosh; Clara J Maxam; Marlie M Maestas; Kelsey E Quinn; Ryan L Ashley
Journal:  Am J Reprod Immunol       Date:  2019-09-10       Impact factor: 3.777

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.